# Ajanta Pharma Ltd (AJANTPHARM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹3081.5
Day Change: -0.84%
52W High: ₹3300
52W Low: ₹2022.05
Market Cap: ₹39,663 Cr

## Valuation
P/E: 39.14
P/B: 9.19
EPS: ₹81.11
Book Value: ₹362.41
Dividend Yield: 0.86%

## Returns
1Y Return: 23.16%

## Profitability
ROE: 25.39%
ROCE: 59.88%
Debt/Equity: 0.06
Revenue Growth: 21.5%
Profit Growth: 18.6%
EBITDA Margin: 27.47%
Operating Margin: 23.19%

## About
Ajanta Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Ajanta Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- BSE Filing: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

## Access
Current tier: anonymous
More history: Register free to see 12 more years.

## Data Freshness
Quote Updated: 2026-05-25T14:00:11.436Z
Price History Updated: 2026-05-25T05:24:18.061Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:18.061Z
Quant Updated: 2026-05-25T05:24:18.061Z
Sentiment Updated: 2026-05-25T05:24:18.061Z
Financials Status: current
Financials Updated: 2026-05-19T01:15:29.708Z
Financials Last Attempt: 2026-05-19T01:15:29.708Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (FY26)
Revenue: ₹5452.86 Cr
Operating Profit: ₹2804.81 Cr (OPM 51.44%)
Net Profit: ₹1056 Cr
Tax: ₹321.65 Cr

## Annual P&L History
FY26: Rev ₹5452.86Cr | PAT ₹1056Cr | OPM 51.44%
FY25: Rev ₹4648.1Cr | PAT ₹920.39Cr | OPM 50.42%
FY24: Rev ₹4161.59Cr | PAT ₹816.17Cr | OPM 25.13%

## Balance Sheet (FY26)
Total Assets: ₹6154.84 Cr
Total Liabilities: ₹1627.75 Cr
Borrowings: ₹260.17 Cr
Cash: ₹103.26 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Yogesh Mannalal Agrawal M.B.A, MD & Executive Director
- Rajesh Mannalal Agrawal M.B.A, Joint MD & Director
- Madhusudan Bhagwandas Agrawal B.Sc, Executive Vice Chairman of the Board
- Arvind K. Agrawal B Com, F.C.A, L.L.B, Chief Financial Officer
- Gaurang Chinubhai Shah, Senior VP of Legal, VP of Corporate Affairs, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/ajantpharm
Disclaimer: For research and education only. Not investment advice.